Hoang Quy Nguyen

Papers on Lattice

Total citations

Topics

h-index

Publication activitypapers/week, last 8 weeks

Frequent co-authors

Thi Hong Duc Phan (1)

Papers (1)

Sep 7, 2026

Thi Hong Duc Phan +1Sep 7, 2026

First-line CDK4/6 inhibitor treatment of HR-positive, HER2-negative metastatic breast cancer: real-world data from Ho Chi Minh City Oncology Hospital, Vietnam

CDK4/6 inhibitors (ribociclib or palbociclib or palbociclib) combined with endocrine therapy demonstrated favorable efficacy and tolerability in Vietnamese patients with HR-positive, HER2-negative metastatic breast cancer.

Thi Hong Duc Phan, Hoang Quy Nguyen

Hoang Quy Nguyen

Publication activitypapers/week, last 8 weeks

Frequent co-authors

Papers (1)

Search

Hoang Quy Nguyen

Publication activitypapers/week, last 8 weeks

Frequent co-authors

Papers (1)